• piecat@lemmy.world
        link
        fedilink
        English
        arrow-up
        32
        ·
        1 year ago

        There is some level of R&D they do to productize it, manufacturability and scaling. And running drug safety trials cannot be cheap, especially the liability insurance.

        That all said, I think it’s criminal that the university labs pay so little. PhD students barely make over $40k, set by the NIH. Not adjusted for CoL either.

        I think I have more of an issue with the for-profit nature of pharma companies. Shareholders shouldn’t be involved in medicine.

      • artic@lemmy.blahaj.zone
        link
        fedilink
        English
        arrow-up
        36
        arrow-down
        7
        ·
        1 year ago

        I hate corporations i hate corporations i hate corporations I hate corporations i hate corporations i hate corporations I hate corporations i hate corporations i hate corporations I hate corporations i hate corporations i hate corporations I hate corporations i hate corporations i hate corporations I hate corporations i hate corporations i hate corporations

      • Pyr_Pressure@lemmy.ca
        link
        fedilink
        English
        arrow-up
        15
        ·
        edit-2
        1 year ago

        The woman who got the nobel prize for the mRNA research that led to the Pfizer vaccine did a lot of it while employed at Pennsylvania University before they fired her because they didn’t see the research leading to making them money. Then she moved on to Biontech where she continued the research.

        I’m not sure how much was done at the university but it was probably not insignificant and then biontech got lucky and snapped it up for basically free.

      • frezik@midwest.social
        link
        fedilink
        English
        arrow-up
        9
        ·
        1 year ago

        I’m always curious about the actual numbers. Here’s their R&D budget by year:

        https://www.statista.com/statistics/267810/expenditure-on-research-and-development-at-pfizer-since-2006/

        And their overall revenue:

        https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/performance/

        In 2020, their revenue was about $40B on $8.5B in R&D cost. They had a huge revenue increase the last few years, with 2022 being $100B, but R&D only increased to about $11B.

        So they do have R&D, but it’s not that big compared to the money they’re bringing in. Their net income has increased substantially, as well.

          • IDontHavePantsOn@lemm.ee
            link
            fedilink
            English
            arrow-up
            3
            ·
            1 year ago

            In the bio industries R&D has almost exclusively become just the D. We like to think that there are a bunch of scientists doing lifelong, painstaking research to develop new drugs or treatments within the labs at Pfizer, Merk, Lilly, or whatever, but a significant portion of the research is done at small independent or school funded labs.

            Once one of those small labs creates a decent treatment that will likely pass government testing, a large corp will buy it and say “We just made this brand new thing!”. Really though, their R&D budget is spent on acquisition, production, supply chain development, and marketing.

            • Average_Squid@sh.itjust.works
              link
              fedilink
              English
              arrow-up
              3
              ·
              1 year ago

              Working in R&D in a few different positions in my career and this is absolutely the case. Hell some of them you could equate to white label SaaS products. Using research from universities putting it in a neat package and selling it.

              • IDontHavePantsOn@lemm.ee
                link
                fedilink
                English
                arrow-up
                3
                ·
                edit-2
                1 year ago

                The corporate bio industry is so fucked up I can’t even begin to describe it. I tell my friends and family stories, but I sound like an insane person to them. The scale at which money is thrown around is just too large for most people to imagine.

                Like this: imagine a worker that makes less than $35k per year processes, and is soley responsible for $20M in products, per month. Product that people all around the world not only use, but ingest. Now imagine that that one worker is the only one in the world who knows how that product is processed. That’s how bio manufacturers work.

        • AEsheron@lemmy.world
          link
          fedilink
          English
          arrow-up
          1
          ·
          1 year ago

          In addition to that, I’ve heard that a large portion of that R&D spending is on iterating drugs they already own so that when the patent runs out they can patent a new version and lobby the old one to be made obsolete so generics can’t be made.

    • uis@lemmy.world
      link
      fedilink
      English
      arrow-up
      8
      arrow-down
      1
      ·
      edit-2
      1 year ago

      AFAIK some US agency did R&D for COVID, they just bribed sponsored Right People